Literature DB >> 29321326

The Amino Terminus of Herpes Simplex Virus 1 Glycoprotein K (gK) Is Required for gB Binding to Akt, Release of Intracellular Calcium, and Fusion of the Viral Envelope with Plasma Membranes.

Farhana Musarrat1, Nithya Jambunathan1, Paul J F Rider1, V N Chouljenko1, K G Kousoulas2.   

Abstract

Previously, we have shown that the amino terminus of glycoprotein K (gK) binds to the amino terminus of gB and that deletion of the amino-terminal 38 amino acids of gK prevents herpes simplex virus 1 (HSV-1) infection of mouse trigeminal ganglia after ocular infection and virus entry into neuronal axons. Recently, it has been shown that gB binds to Akt during virus entry and induces Akt phosphorylation and intracellular calcium release. Proximity ligation and two-way immunoprecipitation assays using monoclonal antibodies against gB and Akt-1 phosphorylated at S473 [Akt-1(S473)] confirmed that HSV-1(McKrae) gB interacted with Akt-1(S473) during virus entry into human neuroblastoma (SK-N-SH) cells and induced the release of intracellular calcium. In contrast, the gB specified by HSV-1(McKrae) gKΔ31-68, lacking the amino-terminal 38 amino acids of gK, failed to interact with Akt-1(S473) and induce intracellular calcium release. The Akt inhibitor miltefosine inhibited the entry of McKrae but not the gKΔ31-68 mutant into SK-N-SH cells. Importantly, the entry of the gKΔ31-68 mutant but not McKrae into SK-N-SH cells treated with the endocytosis inhibitors pitstop-2 and dynasore hydrate was significantly inhibited, indicating that McKrae gKΔ31-68 entered via endocytosis. These results suggest that the amino terminus of gK functions to regulate the fusion of the viral envelope with cellular plasma membranes.IMPORTANCE HSV-1 glycoprotein B (gB) functions in the fusion of the viral envelope with cellular membranes during virus entry. Herein, we show that a deletion in the amino terminus of glycoprotein K (gK) inhibits gB binding to Akt-1(S473), the release of intracellular calcium, and virus entry via fusion of the viral envelope with cellular plasma membranes.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Akt; HSV-1; calcium signaling; fusion; glycoprotein B (gB); glycoprotein K (gK)

Mesh:

Substances:

Year:  2018        PMID: 29321326      PMCID: PMC5827371          DOI: 10.1128/JVI.01842-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  94 in total

1.  Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway.

Authors:  Anthony V Nicola; Jean Hou; Eugene O Major; Stephen E Straus
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

2.  A replication competent HSV-1(McKrae) with a mutation in the amino-terminus of glycoprotein K (gK) is unable to infect mouse trigeminal ganglia after cornea infection.

Authors:  Ahmad A Saied; V N Chouljenko; Ramesh Subramanian; K G Kousoulas
Journal:  Curr Eye Res       Date:  2014-01-08       Impact factor: 2.424

3.  Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Authors:  R I Montgomery; M S Warner; B J Lum; P G Spear
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

4.  The herpes simplex virus type 1 UL20 protein and the amino terminus of glycoprotein K (gK) physically interact with gB.

Authors:  Vladimir N Chouljenko; Arun V Iyer; Sona Chowdhury; Joohyun Kim; Konstantin G Kousoulas
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

5.  Fine mapping of mutations in the fusion-inducing MP strain of herpes simplex virus type 1.

Authors:  K L Pogue-Geile; G T Lee; S K Shapira; P G Spear
Journal:  Virology       Date:  1984-07-15       Impact factor: 3.616

6.  Contributions of gD receptors and glycosaminoglycan sulfation to cell fusion mediated by herpes simplex virus 1.

Authors:  T Terry-Allison; R I Montgomery; M S Warner; R J Geraghty; P G Spear
Journal:  Virus Res       Date:  2001-04       Impact factor: 3.303

7.  A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry.

Authors:  D Shukla; J Liu; P Blaiklock; N W Shworak; X Bai; J D Esko; G H Cohen; R J Eisenberg; R D Rosenberg; P G Spear
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

8.  Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines.

Authors:  K Nakatani; D A Thompson; A Barthel; H Sakaue; W Liu; R J Weigel; R A Roth
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

9.  The UL45 gene product is required for herpes simplex virus type 1 glycoprotein B-induced fusion.

Authors:  E J Haanes; C M Nelson; C L Soule; J L Goodman
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells.

Authors:  Anthony V Nicola; Anna M McEvoy; Stephen E Straus
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more
  15 in total

1.  Differential Requirements for gE, gI, and UL16 among Herpes Simplex Virus 1 Syncytial Variants Suggest Unique Modes of Dysregulating the Mechanism of Cell-to-Cell Spread.

Authors:  Jillian C Carmichael; John W Wills
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

2.  Cellular and Viral Determinants of HSV-1 Entry and Intracellular Transport towards Nucleus of Infected Cells.

Authors:  Farhana Musarrat; Vladimir Chouljenko; Konstantin G Kousoulas
Journal:  J Virol       Date:  2021-01-20       Impact factor: 5.103

Review 3.  Role of Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein K (gK) Pathogenic CD8+ T Cells in Exacerbation of Eye Disease.

Authors:  Ujjaldeep Jaggi; Shaohui Wang; Kati Tormanen; Harry Matundan; Alexander V Ljubimov; Homayon Ghiasi
Journal:  Front Immunol       Date:  2018-12-07       Impact factor: 7.561

4.  Go go gadget glycoprotein!: HSV-1 draws on its sizeable glycoprotein tool kit to customize its diverse entry routes.

Authors:  Adam T Hilterbrand; Ekaterina E Heldwein
Journal:  PLoS Pathog       Date:  2019-05-09       Impact factor: 6.823

5.  Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials.

Authors:  David I Bernstein; Rhonda D Cardin; Derek A Pullum; Fernando J Bravo; Konstantin G Kousoulas; David A Dixon
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

6.  The herpes simplex virus 1 Us3 kinase is involved in assembly of membranes needed for viral envelopment and in distribution of glycoprotein K.

Authors:  Kurt Tobler; Claudia Senn; Elisabeth M Schraner; Mathias Ackermann; Cornel Fraefel; Peter Wild
Journal:  F1000Res       Date:  2019-05-23

7.  Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis.

Authors:  Shan K Naidu; Rafiq Nabi; Nagarjuna R Cheemarla; Brent A Stanfield; Paul J Rider; Nithya Jambunathan; Vladimir N Chouljenko; Renee Carter; Fabio Del Piero; Ingeborg Langohr; Konstantin G Kousoulas
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

8.  Identification and Visualization of Functionally Important Domains and Residues in Herpes Simplex Virus Glycoprotein K(gK) Using a Combination of Phylogenetics and Protein Modeling.

Authors:  Paul J F Rider; Lyndon M Coghill; Misagh Naderi; Jeremy M Brown; Michal Brylinski; Konstantin G Kousoulas
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

Review 9.  Pathogenesis of Herpes Stromal Keratitis: Immune Inflammatory Response Mediated by Inflammatory Regulators.

Authors:  Li Wang; Runbiao Wang; Chuyang Xu; Hongyan Zhou
Journal:  Front Immunol       Date:  2020-05-13       Impact factor: 7.561

10.  Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model.

Authors:  Ifeanyi Kingsley Uche; Natalie Fowlkes; Luan Vu; Tatiane Watanabe; Mariano Carossino; Rafiq Nabi; Fabio Del Piero; Jared S Rudd; Konstantin G Kousoulas; Paul J F Rider
Journal:  J Virol       Date:  2021-01-13       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.